| Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients J Díez, R Querejeta, B López, A González, M Larman, JL Martínez Ubago Circulation 105 (21), 2512-2517, 2002 | 805 | 2002 |
| Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy CY Ho, B López, OR Coelho-Filho, NK Lakdawala, AL Cirino, P Jarolim, ... New England Journal of Medicine 363 (6), 552-563, 2010 | 696 | 2010 |
| Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis R Querejeta, B López, A González, E Sánchez, M Larman, ... Circulation 110 (10), 1263-1268, 2004 | 545 | 2004 |
| Myocardial interstitial fibrosis in heart failure: biological and translational perspectives A González, EB Schelbert, J Díez, J Butler Journal of the American College of Cardiology 71 (15), 1696-1706, 2018 | 512 | 2018 |
| Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure B López, R Querejeta, A González, E Sánchez, M Larman, J Díez Journal of the American College of Cardiology 43 (11), 2028-2035, 2004 | 430 | 2004 |
| Prevalence of left ventricular diastolic dysfunction in a general population T Kuznetsova, L Herbots, B López, Y Jin, T Richart, L Thijs, A González, ... Circulation: Heart Failure 2 (2), 105-112, 2009 | 424 | 2009 |
| Myocardial fibrosis: biomedical research from bench to bedside M Gyöngyösi, J Winkler, I Ramos, QT Do, H Firat, K McDonald, ... European journal of heart failure 19 (2), 177-191, 2017 | 377 | 2017 |
| Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients B López, R Querejeta, N Varo, A González, M Larman, JL Martínez Ubago, ... Circulation 104 (3), 286-291, 2001 | 363 | 2001 |
| Bone marrow cells adopt the cardiomyogenic fate in vivo M Rota, J Kajstura, T Hosoda, C Bearzi, S Vitale, G Esposito, G Iaffaldano, ... Proceedings of the National Academy of Sciences 104 (45), 17783-17788, 2007 | 359 | 2007 |
| Myocardial titin hypophosphorylation importantly contributes to heart failure with preserved ejection fraction in a rat metabolic risk model N Hamdani, C Franssen, A Lourenço, I Falcão-Pires, D Fontoura, S Leite, ... Circulation: Heart Failure 6 (6), 1239-1249, 2013 | 332 | 2013 |
| Reverse myocardial remodeling following valve replacement in patients with aortic stenosis TA Treibel, R Kozor, R Schofield, G Benedetti, M Fontana, AN Bhuva, ... Journal of the American College of Cardiology 71 (8), 860-871, 2018 | 320 | 2018 |
| Alterations in the pattern of collagen deposition may contribute to the deterioration of systolic function in hypertensive patients with heart failure B López, A González, R Querejeta, M Larman, J Díez Journal of the American College of Cardiology 48 (1), 89-96, 2006 | 320 | 2006 |
| Role of lysyl oxidase in myocardial fibrosis: from basic science to clinical aspects B López, A González, N Hermida, F Valencia, E de Teresa, J Díez American Journal of Physiology-Heart and Circulatory Physiology 299 (1), H1-H9, 2010 | 303 | 2010 |
| Circulating biomarkers of collagen metabolism in cardiac diseases B López, A González, J Díez Circulation 121 (14), 1645-1654, 2010 | 303 | 2010 |
| Circulating biomarkers of myocardial fibrosis: the need for a reappraisal B López, A González, S Ravassa, J Beaumont, MU Moreno, G San José, ... Journal of the American College of Cardiology 65 (22), 2449-2456, 2015 | 292 | 2015 |
| The long noncoding RNA Wisper controls cardiac fibrosis and remodeling R Micheletti, I Plaisance, BJ Abraham, A Sarre, CC Ting, M Alexanian, ... Science translational medicine 9 (395), eaai9118, 2017 | 279 | 2017 |
| Identification of a potential cardiac antifibrotic mechanism of torasemide in patients with chronic heart failure B López, A González, J Beaumont, R Querejeta, M Larman, J Díez Journal of the American College of Cardiology 50 (9), 859-867, 2007 | 257 | 2007 |
| T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy CY Ho, SA Abbasi, TG Neilan, RV Shah, Y Chen, B Heydari, AL Cirino, ... Circulation: Cardiovascular Imaging 6 (3), 415-422, 2013 | 255 | 2013 |
| Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure … C Maack, M Lehrke, J Backs, FR Heinzel, JS Hulot, N Marx, WJ Paulus, ... European Heart Journal 39 (48), 4243-4254, 2018 | 248 | 2018 |
| Mechanisms of disease: pathologic structural remodeling is more than adaptive hypertrophy in hypertensive heart disease J Díez, A González, B López, R Querejeta Nature clinical practice Cardiovascular medicine 2 (4), 209-216, 2005 | 244 | 2005 |
